BioSpace News Archive

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced that its open label, single arm US Phase 1 trial met its primary objective of demonstrating the safety of Liposomal Annamycin (“Annamycin”) in treating relapsed or refractory acute myeloid leukemia (“AML”).

Precigen, Inc. announced the closing of its previously announced sale of a number of its bioengineering assets and the related sale of $35 million of its common stock to an affiliate of Third Security LLC.

Allergan plc (NYSE: AGN) announced today its Be The Difference philanthropic program supporting children and their families who may benefit from treatment with BOTOX® (onabotulinumtoxinA) for pediatric upper limb spasticity.

Catalent, Inc. (NYSE: CTLT), and MaSTherCell Global, Inc., a technology-focused cell and gene therapy contract development and manufacturing organization to leading cell therapy innovators, today announced that Catalent has agreed to acquire MaSTherCell Global

Global Blood Therapeutics, Inc. announced that on February 1, 2020, the compensation committee of GBT’s board of directors granted seven new employees options to purchase an aggregate of 16,000 shares of the company’s common stock with a per share exercise price of $65.26 and restricted stock units for an aggregate of 41,450 shares of the company’s common stock.

VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, announced today that Prof. Dror Harats, M.D., Chief Executive Officer, will present a corporate overview at the BIO CEO & Investor Conference,

Patients from 30 Countries / Territories and 47 States Traveled to CIGC for Groundbreaking Minimally Invasive Surgical Techniques

The number of confirmed cases of coronavirus (2019-nCoV) has reached 17,489, with 362 deaths, as of the morning of Feb 3, according to the interactive map provided by Johns Hopkins CSSE (Center for Systems Science and Engineering)

Anritsu Instruments Supporting 3G/4G/5G and Wi-Fi to be Used by Eurofins E&E to Ensure Performance, Compatibility, and Compliance of Wireless and Radio Devices

Acoer, developer of blockchain-enabled applications, announced that it is helping its healthcare and life sciences clients to easily track and visualize the Coronavirus outbreak with its HashLog data visualization engine.